首页> 美国政府科技报告 >Drug and Vaccine evaluation in the Human Aotus Plasmodium falciparum Model
【24h】

Drug and Vaccine evaluation in the Human Aotus Plasmodium falciparum Model

机译:人类aotus plasmodium falciparum模型中的药物和疫苗评估

获取原文

摘要

Next generation quinoline methanol (NGQM) lead analog 8SF5MQ (WR 319689) when administered to Aotus monkeys infected with Plasmodium falciparum FVO orally at 6.25 mg/kg cleared and recrudesce but at 2.1 mg/kg had no effect over parasitemia. In contrast, mefloquine at 6.25 mg/kg cleared and cured but at 2.1 mg/kg only suppressed. Additionally, we were able to cryopreserved Aotus blood at high density parasitemias > 50 x 1000 x microL for both Plasmodium vivax AMRU-1 and P. vivax SAL-1 parasites that will be used at WRAIR for in vitro culture experiments. In another series of experiments, WR621308 at 65 m/kg suppressed parasitemia in Aotus infected with P. falciparum FVO but toxic adverse effects observed in one animal stopped the experiment at a higher dose (130 mg/kg).

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号